| scholarly article | Q13442814 |
| P356 | DOI | 10.2152/JMI.57.152 |
| P8608 | Fatcat ID | release_6lqxy4dxcngirjhvn5qmjjruye |
| P698 | PubMed publication ID | 20299755 |
| P5875 | ResearchGate publication ID | 42345340 |
| P2093 | author name string | Tomoya Fukawa | |
| Tomoharu Fukumori | |||
| Hiro-omi Kanayama | |||
| Hiroyoshi Nakatsuji | |||
| Manabu Sakaki | |||
| Avirmed Shiirevnyamba | |||
| Essam Elsamman | |||
| P433 | issue | 1-2 | |
| P304 | page(s) | 152-157 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | Journal of Medical Investigation | Q15754331 |
| P1476 | title | Clinical significance of Galectin-3 in clear cell renal cell carcinoma | |
| P478 | volume | 57 |
| Q45884221 | Anguilla japonica lectin 1 delivery through adenovirus vector induces apoptotic cancer cell death through interaction with PRMT5. |
| Q37197649 | Antitumor effects of galectin-3 inhibition in human renal carcinoma cells |
| Q35563015 | Changes in the expression and subcellular distribution of galectin-3 in clear cell renal cell carcinoma |
| Q33940919 | Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells |
| Q38942488 | Effect of galectin-3 on the behavior of Eca‑109 human esophageal cancer cells |
| Q34676070 | Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function |
| Q43839578 | Expression of galectin-3 in pancreatic ductal adenocarcinoma |
| Q33631354 | Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma |
| Q21134996 | Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkers |
| Q47329197 | Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). |
| Q44523706 | Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence |
| Q91674866 | Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma |
| Q50602124 | Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma |
| Q38269048 | Galectins in cancer: carcinogenesis, diagnosis and therapy |
| Q36390226 | Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells |
| Q37319119 | Immunohistochemical clue for the histological overlap of salivary adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma |
| Q34360666 | Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide |
| Q36924436 | Investigation of the Roles of Cyclooxygenase-2 and Galectin-3 Expression in the Pathogenesis of Premenopausal Endometrial Polyps |
| Q33653371 | Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer |
| Q84066530 | Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma |
| Q53431665 | RETRACTED: Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells. |
| Q29994848 | Spindle pole cohesion requires glycosylation-mediated localization of NuMA. |
| Q26752754 | The Role of Galectin-3 in the Kidneys |
| Q35915348 | The expression and significance of Gal-3 and MUC1 in colorectal cancer and colon cancer |
| Q53183087 | The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma. |
Search more.